{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:41:50Z","timestamp":1775853710444,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00403-020-02132-8","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T16:02:27Z","timestamp":1599321747000},"page":"549-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Botulinum toxin type A versus 5-Fluorouracil in treatment of keloid"],"prefix":"10.1007","volume":"313","author":[{"given":"Sahar A.","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorhan H. K.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sotohy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8233","authenticated-orcid":false,"given":"Doaa A. E.","family":"Abou-Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"2132_CR1","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/GOX.0b013e31829c4597","volume":"1","author":"C Huang","year":"2013","unstructured":"Huang C, Murphy GF, Akaishi S et al (2013) Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open 1:e25","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2132_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PRS.0b013e3181c82dd5","volume":"125","author":"R Ogawa","year":"2010","unstructured":"Ogawa R (2010) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 125:557\u2013568","journal-title":"Plast Reconstr Surg"},{"key":"2132_CR3","first-page":"1","volume":"00","author":"DAE Abou-Taleb","year":"2020","unstructured":"Abou-Taleb DAE, Badary DM (2020) Intralesional verapamil in the treatment of keloids: a clinical, histopathological and immunohistochemical study. J Cosmet Dermatol 00:1\u20137","journal-title":"J Cosmet Dermatol"},{"key":"2132_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ijd.12436","volume":"53","author":"LY Kerwin","year":"2014","unstructured":"Kerwin LY, El Tal AK, Stiff MA, Fakhouri TM (2014) Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches. Int J Dermatol 53:922\u2013936","journal-title":"Int J Dermatol"},{"key":"2132_CR5","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.bjps.2013.06.004","volume":"66","author":"L Huang","year":"2013","unstructured":"Huang L, Cai YJ, Lung I, Leung BC, Burd A (2013) A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. J Plast Reconstr Aesthet Surg 66:e251\u2013e259","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2132_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5999\/aps.2014.41.6.620","volume":"41","author":"AT Perdanasari","year":"2014","unstructured":"Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke L, Min P, Feng S, Zhang YX, Persichetti P (2014) Recent developments in the use of intralesional injections keloid treatment. Arch Plast Surg 41:620","journal-title":"Arch Plast Surg"},{"key":"2132_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1440-0960.2004.00072.x","volume":"45","author":"M Apikian","year":"2004","unstructured":"Apikian M, Goodman G (2004) Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 45:140\u2013143","journal-title":"Australas J Dermatol"},{"key":"2132_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","volume":"33","author":"Z Xiao","year":"2009","unstructured":"Xiao Z, Zhang F, Cui Z (2009) Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthet Plast Surg 33:409\u2013412","journal-title":"Aesthet Plast Surg"},{"key":"2132_CR9","doi-asserted-by":"publisher","first-page":"275e","DOI":"10.1097\/PRS.0b013e3181b98ee7","volume":"124","author":"X Zhibo","year":"2009","unstructured":"Zhibo X, Miaobo Z (2009) Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg 124:275e\u2013277e","journal-title":"Plast Reconstr Surg"},{"key":"2132_CR10","first-page":"20","volume":"3","author":"MH Viera","year":"2010","unstructured":"Viera MH, Amini S, Valins W, Berman B (2010) Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol 3:20","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"2132_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/DSS.0000000000001360","volume":"44","author":"E Austin","year":"2018","unstructured":"Austin E, Koo E, Jagdeo J (2018) The cellular response of keloids and hypertrophic scars to botulinum toxin A: a comprehensive literature review. Dermatol Surg 44(2):149\u2013157","journal-title":"Dermatol Surg"},{"key":"2132_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4065\/81.8.1023","volume":"81","author":"HG Gassner","year":"2006","unstructured":"Gassner HG, Brissett AE, Otley CC, Boahene DK, Boggust AJ, Weaver AL, Sherris DA (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81(8):1023\u20131028","journal-title":"Mayo Clin Proc"},{"issue":"25","key":"2132_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000342125","volume":"2012","author":"G Gauglitz","year":"2012","unstructured":"Gauglitz G, Bureik D, Dombrowski Y, Pavicic T, Ruzicka T, Schauber J (2012) Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol 25:313\u2013318","journal-title":"Skin Pharmacol Physiol"},{"key":"2132_CR14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7123\/01.EJDV.0000431207.04926.59","volume":"33","author":"N Ghonaim","year":"2013","unstructured":"Ghonaim N (2013) Comparative study of the 80% trichloroacetic acid multiple puncture technique versus botulinum toxin type A in the treatment of keloid scars. Egypt J Dermatol Venerol 33:22","journal-title":"Egypt J Dermatol Venerol"},{"key":"2132_CR15","first-page":"54","volume":"30","author":"S Nanda","year":"2004","unstructured":"Nanda S, Reddy BSN (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 30:54\u201357","journal-title":"Dermatol Surg"},{"key":"2132_CR16","first-page":"778","volume":"95","author":"E Bijlard","year":"2015","unstructured":"Bijlard E, Steltenpool S, Niessen FB (2015) Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 95:778\u2013782","journal-title":"Acta Derm Venereol"},{"key":"2132_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2007.12.001","volume":"206","author":"PD Butler","year":"2008","unstructured":"Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206:731\u2013741","journal-title":"J Am Coll Surg"},{"key":"2132_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00266-006-0253-y","volume":"31","author":"BS Atiyeh","year":"2007","unstructured":"Atiyeh BS (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 31:468\u2013492","journal-title":"Aesthetic Plast Surg"},{"key":"2132_CR19","unstructured":"J\u00fanior O (2007) Estudo comparativo entre o tratamento radioter\u00e1pico com el\u00e9trons e betaterapia ap\u00f3s cirurgia de quel\u00f3ide."},{"key":"2132_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaad.2004.09.018","volume":"52","author":"G Kontochristopoulos","year":"2005","unstructured":"Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, Stefanaki K, Argyrakos T, Petridis A, Katsambas A (2005) Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 52:474\u2013479","journal-title":"J Am Acad Dermatol"},{"key":"2132_CR21","first-page":"309","volume":"25","author":"AD Maderal","year":"2012","unstructured":"Maderal AD, Vivas AC, Tang JC, Viera MH (2012) REVIEWS-hypertrophic scars and keloids, part 1: conventional treatments. Cosmet Dermatol 25:309","journal-title":"Cosmet Dermatol"},{"key":"2132_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/jocd.12134","volume":"14","author":"E Shaarawy","year":"2015","unstructured":"Shaarawy E, Hegazy RA, Hay RMA (2015) Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol 14:161\u2013166","journal-title":"J Cosmet Dermatol"},{"key":"2132_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000051830","volume":"204","author":"S Gupta","year":"2002","unstructured":"Gupta S, Kalra A (2002) Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 204:130\u2013132","journal-title":"Dermatology"},{"key":"2132_CR24","first-page":"32","volume":"20","author":"AM Kabel","year":"2016","unstructured":"Kabel AM, Sabry HH, Sorour NE, Moharm FM (2016) Comparative study between intralesional injection of bleomycin and 5-fluorouracil in the treatment of keloids and hypertrophic scars. J Dermatol Surg 20:32\u201338","journal-title":"J Dermatol Surg"},{"key":"2132_CR25","first-page":"1446","volume":"111","author":"A Naeini","year":"2006","unstructured":"Naeini A, Mueller RV, Xi G, Sipe R, Buck D, Hollinger J (2006) Mast cells: an unexpected finding in the modulation of cutaneous wound repair by charged beads. Plast Reconst Surg 111:1446\u20131453","journal-title":"Plast Reconst Surg"},{"key":"2132_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1524-4725.1999.08165.x","volume":"25","author":"RE Fitzpatrick","year":"1999","unstructured":"Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25:224\u2013232","journal-title":"Dermatol Surg"},{"key":"2132_CR27","first-page":"1293","volume":"140","author":"CC Robinson","year":"2013","unstructured":"Robinson CC, Rosenberger AD, Forster T, Beller G, Kratzsch M, Felsenberg D (2013) Modification of a device and its application for intralesional cryosurgery of old recalcitrant keloids. Arch Dermatol 140:1293\u20131294","journal-title":"Arch Dermatol"},{"issue":"1","key":"2132_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3342\/ceo.2009.2.1.20","volume":"2","author":"SG Wang","year":"2009","unstructured":"Wang SG, Lee BJ, Jeong JH, Lee JC, Goh EK, Kim HW (2009) Effect of botulinum toxin type A on a rat surgical wound model. Clin Exp Otorhinolaryngol 2(1):20\u201327","journal-title":"Clin Exp Otorhinolaryngol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02132-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T06:54:52Z","timestamp":1723532092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02132-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}